3SBio Inc.: all 106 studies
Page 2 of 2. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.
- A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy SubjectsCompletedNCT02460393Phase 1
- rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic CharacteristicsStatus unknownNCT02356419Phase 1
- The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLCStatus unknownNCT02344979
- Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's LymphomaCompletedNCT01459887Phase 3
- Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast CancerCompletedNCT01439191Phase 2
- Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinECompletedNCT01291667